Page last updated: 2024-08-25

7-hydroxystaurosporine and Carcinoma, Non-Small Cell Lung

7-hydroxystaurosporine has been researched along with Carcinoma, Non-Small Cell Lung in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Edelman, MJ; Gandara, DR; Gumerlock, PH; Lara, PN; Lau, AH; Mack, PC1
Gandara, DR; Goldberg, Z; Gumerlock, PH; Gustafsson, MH; Jones, AA; Mack, PC1
Saijo, N1
Jiang, H; Yang, LY1
Bowen, C; Edelman, MJ; Gandara, DR; Gelmann, EP; Gumerlock, PH; Mack, PC; Paglieroni, T; Schnier, JB1

Reviews

1 review(s) available for 7-hydroxystaurosporine and Carcinoma, Non-Small Cell Lung

ArticleYear
New chemotherapeutic agents for the treatment of non-small cell lung cancer: the Japanese experience.
    Chest, 1998, Volume: 113, Issue:1 Suppl

    Topics: Alkaloids; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carbazoles; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Docetaxel; Glucosides; Humans; Irinotecan; Japan; Lung Neoplasms; Mitomycin; Mitomycins; Neoplasms, Experimental; Paclitaxel; Purine Nucleosides; Staurosporine; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine

1998

Other Studies

4 other study(ies) available for 7-hydroxystaurosporine and Carcinoma, Non-Small Cell Lung

ArticleYear
Cell cycle-dependent potentiation of cisplatin by UCN-01 in non-small-cell lung carcinoma.
    Cancer chemotherapy and pharmacology, 2003, Volume: 51, Issue:4

    Topics: Alkaloids; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Cycle Proteins; Cisplatin; Drug Synergism; Humans; Lung Neoplasms; Phosphorylation; Staurosporine; Tumor Cells, Cultured

2003
Enhancement of radiation cytotoxicity by UCN-01 in non-small cell lung carcinoma cells.
    Radiation research, 2004, Volume: 162, Issue:6

    Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; G2 Phase; Humans; Lung Neoplasms; Protein Kinase Inhibitors; Staurosporine; Tumor Suppressor Protein p53

2004
Cell cycle checkpoint abrogator UCN-01 inhibits DNA repair: association with attenuation of the interaction of XPA and ERCC1 nucleotide excision repair proteins.
    Cancer research, 1999, Sep-15, Volume: 59, Issue:18

    Topics: Alkaloids; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Cycle; DNA Repair; DNA Replication; DNA-Binding Proteins; Endonucleases; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Lung Neoplasms; Proteins; Staurosporine; Tumor Cells, Cultured; Xeroderma Pigmentosum; Xeroderma Pigmentosum Group A Protein

1999
RB status as a determinant of response to UCN-01 in non-small cell lung carcinoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:9

    Topics: Alkaloids; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cyclin-Dependent Kinase Inhibitor p16; Enzyme Inhibitors; G1 Phase; Genes, p53; Genes, Retinoblastoma; Growth Inhibitors; Humans; Lung Neoplasms; Phosphorylation; Retinoblastoma Protein; Staurosporine; Tumor Cells, Cultured; Tumor Suppressor Protein p53

1999